38,838,795 Equity Shares of Supriya Lifescience Limited are subject to a Lock-Up Agreement Ending on 23-DEC-2022. These Equity Shares will be under lockup for 367 days starting from 21-DEC-2021 to 23-DEC-2022.

Details:
Pursuant to Regulations 14 and 16 of the SEBI ICDR Regulations, an aggregate of 20% of the fully diluted post-Offer Equity Share capital of Company held by the Promoter, except for the Equity Shares offered pursuant to the Offer for Sale, shall be locked in for a period of three years as minimum promoter’s contribution from the date of Allotment (“Promoter’s Contribution”), and the Promoter’s shareholding in excess of 20% of the fully diluted post-Offer Equity Share capital shall be locked in for a period of one year from the date of Allotment.

In addition to the 20% of the fully diluted post-Offer shareholding of Company held by the Promoter and locked in for three years as specified above and Equity Shares offered by the Promoter Selling Shareholder as part of the Offer for Sale, the entire pre-Offer Equity Share capital of Company will be locked-in for a period of one year from the date of Allotment, including any unsubscribed portion of the Offer for Sale, in accordance with Regulations 16(b) and 17 of the SEBI ICDR Regulations.